Detalles de la búsqueda
1.
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.
Lancet
; 384(9944): 665-73, 2014 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24933332
2.
Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study.
Lancet Oncol
; 14(6): 543-51, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23583604
3.
Durvalumab in Combination With Olaparib Versus Durvalumab Alone as Maintenance Therapy in Metastatic NSCLC: The Phase 2 ORION Study.
J Thorac Oncol
; 18(11): 1594-1606, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390980
4.
Veliparib in Combination with Carboplatin and Etoposide in Patients with Treatment-Naïve Extensive-Stage Small Cell Lung Cancer: A Phase 2 Randomized Study.
Clin Cancer Res
; 27(14): 3884-3895, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33947690
5.
Exploratory analysis of front-line therapies in REVEL: a randomised phase 3 study of ramucirumab plus docetaxel versus docetaxel for the treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy.
ESMO Open
; 5(1)2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31958290
6.
Dasatinib-induced pulmonary arterial hypertension unresponsive to PDE-5 inhibition.
Eur Respir J
; 42(3): 869-70, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24000257
7.
Successful treatment of azole-resistant invasive aspergillosis in a bottlenose dolphin with high-dose posaconazole.
Med Mycol Case Rep
; 16: 16-19, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28409094
8.
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923.
J Clin Oncol
; 20(19): 3947-55, 2002 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12351591
9.
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?
Int J Radiat Oncol Biol Phys
; 58(5): 1388-93, 2004 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15050314
10.
Phase III, randomized, double-blind, placebo-controlled trial of gemcitabine/cisplatin alone or with sorafenib for the first-line treatment of advanced, nonsquamous non-small-cell lung cancer.
J Clin Oncol
; 30(25): 3084-92, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22851564
11.
A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancer.
Lung Cancer
; 68(3): 420-6, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19692142
12.
Love, psychosis, and boundaries: a resident's first psychotherapy case.
Harv Rev Psychiatry
; 12(3): 165-76, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15371072
13.
Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: a risk-benefit analysis of a large phase III study.
Eur J Cancer
; 45(13): 2298-303, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19473833
14.
Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
Respir Med
; 102(11): 1511-20, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18804362
15.
Awakening to love: R. D. Laing's phenomenological therapy
Psychoanalytic Review
; 87(4): 527-47, 2000.
Artículo
en Inglés
| Bivipsil | ID: psa-107423
Resultados
1 -
15
de 15
1
Próxima >
>>